This announcement is a separate document:
华兰疫苗：安徽承义律师事务所关于华兰生物疫苗股份有限公司2022年限制性股票激励计划首次授予部分第一个归属期归属条件成就及部分限制性股票作废相关事项的法律意见书(1)
Hualan Biological Vaccine Inc.: Legal Opinion of Anhui Chengyi Law Firm on matters relating to Hualan Biovaccine Co., Ltd.'s 2022 Restricted Stock Incentive Plan granted part of the first vesting period, the fulfillment of ownership conditions and the abolition of some restricted shares (1)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated